Men's Health
Revolutionizing Men’s Health & Wellness
Morenova is a next-generation shockwave therapy system capable of incorporating focused shockwaves, linear shockwaves, and large-area shockwave technologies – all with the same platform device. These make it possible to provide optimal therapy for a wide range of sexual health conditions.
Treatment Applications
Morenova’s unique transducers allow for optimal organ coverage of therapeutic low intensity shockwaves – while enabling the only hands-free treatment available today. This enhances treatment comfort for both patient and healthcare provider.
Erectile Dysfunction (ED)
Morenova has proven effective in treating men’s inability to achieve or maintain an erection with sufficient rigidity and duration to have sexual intercourse. By promoting neovascularization and improving blood flow, Morenova targets the root cause of erectile dysfunction without the need for drugs or surgery. It is a hands-free system and the only system on the market utilizing two transducers to apply shockwaves to both sides of the shaft. Treatment consists of non-invasive low-intensity sound waves that pass through the erectile tissue, restoring natural erectile function and enabling spontaneous erections by the growth of new blood vessels, thereby addressing the underlying cause and not just the symptoms.
Two linear transducers are applied simultaneously to the left and right corpus enabling optimal coverage and allowing for a hands-free treatment. The standard protocol for treatment includes six sessions over the course of three weeks. Clinical data shows that the increased function lasts for at least 12 months, after which a repeated course of treatment is recommended.
Chronic Pelvic Pain Syndrome(CPPS)/Chronic Prostatitis (CP)
Morenova has proven to be effective in patients who experience ongoing pain in the pelvic area for at least three months due to an inflammation of the prostate gland. Typically non-responsive to antibiotics, CPP/CP can affect sexual function and the ability to urinate. Morenova significantly improves the symptoms of CPP and CP by using shockwaves to stimulate specific nerves in the painful area, temporarily blocking the signals that transmit pain. In addition, the shockwaves promote the growth of new blood vessels in the damaged tissue and relax and loosen tight muscles, which can also contribute to pain relief.
A 30 mm circumference transducer is positioned on the perineum in order to apply the required acoustic energy to the entire profile of the prostate to address the pain. The standard protocol includes six treatment sessions over the course of three weeks.
Peyronie’s Disease (PD)
Morenova helps to reduce the curvature and pain associated with PD by softening and breaking up the plaque and scar tissue inside the penis. Morenova promotes tissue regeneration, initiates a healing process within the cells, and improves blood flow to the area while reducing common symptoms such as erection problems, shortening of the penis, and pain due to the disease.
A single focused transducer is used in order to apply the required acoustic energy to the region of the scar tissue causing the curvature. A treatment protocol includes six treatment sessions. Additional sessions may be recommended according to the severity of the condition.
Clinical Results
Efficacy, Satisfaction, and Safety of Low-Intensity, Large-Area Shock Wave Therapy With Dual-Probe Energy Delivery for Erectile Dysfunction
A Phase 2 Randomized Trial To Evaluate Different Dose Regimens of Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction Clinical Trial Update
Comparison of the Efficiency of Combined Extracorporeal Shock-Wave Therapy and Triple Therapy Versus Triple Therapy Itself in Category III B Chronic Pelvic Pain Syndrome
Does Shockwave Therapy Have a Place in the Treatment of Peyronie’s Disease
Efficacy and Safety of Extracorporeal Shock Wave Therapy in the Treatment of Chronic Prostatitis Chronic Pelvic Pain Syndrome and Acquired Premature Ejaculation Patients
Efficacy and Safety of Extracorporeal Shockwave Therapy for the Treatment of Chronic Non-Bacterial Prostatitis A Systematic Review and Meta-Analysis
Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome
Extracorporeal Shock Wave Therapy in Peyronie’s Disease Clinical Efficacy and Safety from a Single-Arm Observational Study
Extracorporeal Shockwave Therapy Combined With Drug Therapy in Chronic Pelvic Pain Syndrome A Randomized Clinical Trial
Long-Term Efficacy and Safety of Extracorporeal Shock Wave Therapy Protocols in the Treatment of Chronic Prostatitis Chronic Pelvic Pain Syndrome Patients
Low-Intensity Extracorporeal Shock Wave Therapy for Peyronie’s Disease A Single-Center Experience
Low-Intensity Extracorporeal Shockwave Therapy for Peyronie’s Disease A Preliminary Study of 32 Cases
Video Testimonials
Dr. Arian Iurie
Urologist & Andrologist, Moldova
Dr Ismail Masarwa
Urologist at U-clinic, Israel
Dr Ivo Pineda
Urologist- Andrologist, Mexico
Dr Bruce Howe
Urologist, San Diego, California
Dr Mario Maglione
Medical director of Urolit, Urological center based at the Oultun Institute, Cordoba, Argentina